Cargando…

Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives

Pediatric acute-onset neuropsychiatric syndrome (PANS) features a heterogeneous constellation of acute obsessive-compulsive disorder (OCD), eating restriction, cognitive, behavioral and/or affective symptoms, often followed by a chronic course with cognitive deterioration. An immune-mediated etiolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagliano, Antonella, Carta, Alessandra, Tanca, Marcello G, Sotgiu, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225150/
https://www.ncbi.nlm.nih.gov/pubmed/37251418
http://dx.doi.org/10.2147/NDT.S362202
_version_ 1785050338408005632
author Gagliano, Antonella
Carta, Alessandra
Tanca, Marcello G
Sotgiu, Stefano
author_facet Gagliano, Antonella
Carta, Alessandra
Tanca, Marcello G
Sotgiu, Stefano
author_sort Gagliano, Antonella
collection PubMed
description Pediatric acute-onset neuropsychiatric syndrome (PANS) features a heterogeneous constellation of acute obsessive-compulsive disorder (OCD), eating restriction, cognitive, behavioral and/or affective symptoms, often followed by a chronic course with cognitive deterioration. An immune-mediated etiology is advocated in which the CNS is hit by different pathogen-driven (auto)immune responses. This narrative review focused on recent clinical (ie, diagnostic criteria, pre-existing neurodevelopmental disorders, neuroimaging) and pathophysiological (ie, CSF, serum, genetic and autoimmune findings) aspects of PANS. We also summarized recent points to facilitate practitioners with the disease management. Relevant literature was obtained from PubMed database which included only English-written, full-text clinical studies, case reports, and reviews. Among a total of 1005 articles, 205 were pertinent to study inclusion. Expert opinions are converging on PANS as the effect of post-infectious events or stressors leading to “brain inflammation”, as it is well-established for anti-neuronal psychosis. Interestingly, differentiating PANS from either autoimmune encephalitides and Sydenham’s chorea or from alleged “pure” psychiatric disorders (OCD, tics, Tourette’s syndrome), reveals several overlaps and more analogies than differences. Our review highlights the need for a comprehensive algorithm to help both patients during their acute distressing phase and physicians during their treatment decision. A full agreement on the hierarchy of each therapeutical intervention is missing owing to the limited number of randomized controlled trials. The current approach to PANS treatment emphasizes immunomodulation/anti-inflammatory treatments in association with both psychotropic and cognitive-behavioral therapies, while antibiotics are suggested when an active bacterial infection is established. A dimensional view, taking into account the multifactorial origin of psychiatric disorders, should suggest neuro-inflammation as a possible shared substrate of different psychiatric phenotypes. Hence, PANS and PANS-related disorders should be considered as a conceptual framework describing the etiological and phenotypical complexity of many psychiatric disorders.
format Online
Article
Text
id pubmed-10225150
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-102251502023-05-29 Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives Gagliano, Antonella Carta, Alessandra Tanca, Marcello G Sotgiu, Stefano Neuropsychiatr Dis Treat Review Pediatric acute-onset neuropsychiatric syndrome (PANS) features a heterogeneous constellation of acute obsessive-compulsive disorder (OCD), eating restriction, cognitive, behavioral and/or affective symptoms, often followed by a chronic course with cognitive deterioration. An immune-mediated etiology is advocated in which the CNS is hit by different pathogen-driven (auto)immune responses. This narrative review focused on recent clinical (ie, diagnostic criteria, pre-existing neurodevelopmental disorders, neuroimaging) and pathophysiological (ie, CSF, serum, genetic and autoimmune findings) aspects of PANS. We also summarized recent points to facilitate practitioners with the disease management. Relevant literature was obtained from PubMed database which included only English-written, full-text clinical studies, case reports, and reviews. Among a total of 1005 articles, 205 were pertinent to study inclusion. Expert opinions are converging on PANS as the effect of post-infectious events or stressors leading to “brain inflammation”, as it is well-established for anti-neuronal psychosis. Interestingly, differentiating PANS from either autoimmune encephalitides and Sydenham’s chorea or from alleged “pure” psychiatric disorders (OCD, tics, Tourette’s syndrome), reveals several overlaps and more analogies than differences. Our review highlights the need for a comprehensive algorithm to help both patients during their acute distressing phase and physicians during their treatment decision. A full agreement on the hierarchy of each therapeutical intervention is missing owing to the limited number of randomized controlled trials. The current approach to PANS treatment emphasizes immunomodulation/anti-inflammatory treatments in association with both psychotropic and cognitive-behavioral therapies, while antibiotics are suggested when an active bacterial infection is established. A dimensional view, taking into account the multifactorial origin of psychiatric disorders, should suggest neuro-inflammation as a possible shared substrate of different psychiatric phenotypes. Hence, PANS and PANS-related disorders should be considered as a conceptual framework describing the etiological and phenotypical complexity of many psychiatric disorders. Dove 2023-05-24 /pmc/articles/PMC10225150/ /pubmed/37251418 http://dx.doi.org/10.2147/NDT.S362202 Text en © 2023 Gagliano et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Gagliano, Antonella
Carta, Alessandra
Tanca, Marcello G
Sotgiu, Stefano
Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives
title Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives
title_full Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives
title_fullStr Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives
title_full_unstemmed Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives
title_short Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives
title_sort pediatric acute-onset neuropsychiatric syndrome: current perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225150/
https://www.ncbi.nlm.nih.gov/pubmed/37251418
http://dx.doi.org/10.2147/NDT.S362202
work_keys_str_mv AT gaglianoantonella pediatricacuteonsetneuropsychiatricsyndromecurrentperspectives
AT cartaalessandra pediatricacuteonsetneuropsychiatricsyndromecurrentperspectives
AT tancamarcellog pediatricacuteonsetneuropsychiatricsyndromecurrentperspectives
AT sotgiustefano pediatricacuteonsetneuropsychiatricsyndromecurrentperspectives